Your browser doesn't support javascript.
loading
The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells.
Legler, Karen; Hauser, Charlotte; Egberts, Jan-Hendrik; Willms, Anna; Heneweer, Carola; Boretius, Susann; Röcken, Christoph; Glüer, Claus-Christian; Becker, Thomas; Kluge, Michael; Hill, Oliver; Gieffers, Christian; Fricke, Harald; Kalthoff, Holger; Lemke, Johannes; Trauzold, Anna.
Afiliación
  • Legler K; Institute for Experimental Cancer Research, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Hauser C; Clinic for General Surgery, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Egberts JH; Clinic for General Surgery, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Willms A; Institute for Experimental Cancer Research, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Heneweer C; Clinic for Diagnostic Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Boretius S; Department of Radiology, University Hospital Cologne, Cologne, Germany.
  • Röcken C; Clinic for Diagnostic Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Glüer CC; Functional Imaging Laboratory, German Primate Center, Leibniz Institute for Primate Research and Georg-August-University Göttingen, Göttingen, Germany.
  • Becker T; Institute of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kluge M; Section Biomedical Imaging, Department of Diagnostic Radiology und Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Hill O; Clinic for General Surgery, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Gieffers C; APOGENIX AG, Im Neuenheimer Feld 584, Heidelberg, Germany.
  • Fricke H; Affimed GmbH, Im Neuenheimer Feld 582, Heidelberg, Germany.
  • Kalthoff H; APOGENIX AG, Im Neuenheimer Feld 584, Heidelberg, Germany.
  • Lemke J; APOGENIX AG, Im Neuenheimer Feld 584, Heidelberg, Germany.
  • Trauzold A; APOGENIX AG, Im Neuenheimer Feld 584, Heidelberg, Germany.
Cell Death Dis ; 9(5): 445, 2018 05 01.
Article en En | MEDLINE | ID: mdl-29670075
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteínas Recombinantes de Fusión / Carcinoma Ductal Pancreático / Ligando Inductor de Apoptosis Relacionado con TNF / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cell Death Dis Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteínas Recombinantes de Fusión / Carcinoma Ductal Pancreático / Ligando Inductor de Apoptosis Relacionado con TNF / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cell Death Dis Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido